Table 3. Correlations of ITGA7 expression with clinical characteristics.
Items | ITGA7 expression | P value | |
---|---|---|---|
High | Low | ||
Age, No. (%) | 0.607 | ||
≤60 years | 82 (64.6) | 45 (35.4) | |
>60 years | 88 (61.5) | 55 (38.5) | |
Gender, No. (%) | 0.753 | ||
Male | 135 (62.5) | 81 (37.5) | |
Female | 35 (64.8) | 19 (35.2) | |
Pathological grade, No. (%) | 0.001 | ||
G1 | 18 (42.9) | 24 (57.1) | |
G2 | 107 (63.7) | 61 (36.3) | |
G3 | 45 (75.0) | 15 (25.0) | |
Tumor size, No. (%) | 0.029 | ||
≤5 cm | 54 (54.5) | 45 (45.5) | |
>5 cm | 116 (67.8) | 55 (32.2) | |
LYN, No. (%) | 0.014 | ||
No | 95 (57.2) | 71 (42.8) | |
Yes | 75 (72.1) | 29 (27.9) | |
TNM stage, No. (%) | <0.001 | ||
I | 42 (48.8) | 44 (51.2) | |
II | 55 (64.0) | 31 (36.0) | |
III | 73 (74.5) | 25 (25.5) |
Correlations were determined by Chi-square test or Wilcoxon rank sum test, P value <0.05 was considered significant. ITGA7, integrin-α7; LYN, lymph node metastasis.